Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Downey, D. G
1311  Ergebnisse:
Personensuche X
?
1

EPS3.04 Reversal of levofloxacin resistance in cystic fibro..:

Sloan, C.M. ; Sherrard, L.J. ; Einarsson, G.G...
Journal of Cystic Fibrosis.  23 (2024)  - p. S41 , 2024
Link: https://doi.org/10.1016/..
 
?
2

ECFS standards of care on CFTR-related disorders: Identific..:

Simmonds, N.J. ; Southern, K.W. ; De Wachter, E....
Journal of Cystic Fibrosis.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

EPS9.06 Development of levofloxacin resistance in clinical ..:

Sloan, C.M. ; Sherrard, L.J. ; Einarsson, G.G...
Journal of Cystic Fibrosis.  22 (2023)  - p. S62 , 2023
Link: https://doi.org/10.1016/..
 
?
4

P228 In vitro evolution of levofloxacin resistance in linea..:

Sloan, C.M. ; Sherrard, L.J. ; Einarsson, G.G....
Journal of Cystic Fibrosis.  22 (2023)  - p. S135 , 2023
Link: https://doi.org/10.1016/..
 
?
5

P253 Optimisation of inhaled antibiotic prescribing for Pse..:

Sloan, C.M. ; Sherrard, L.J. ; Einarsson, G.G....
Journal of Cystic Fibrosis.  22 (2023)  - p. S143 , 2023
Link: https://doi.org/10.1016/..
 
?
6

P284 Assessing the potential of the FIB-4 index as a screen..:

Armstrong, S. ; McDougall, N. ; McCorry, R...
Journal of Cystic Fibrosis.  22 (2023)  - p. S152 , 2023
Link: https://doi.org/10.1016/..
 
?
7

P150 Antimicrobial prescribing in people with cystic fibros..:

Sloan, C.M. ; Sherrard, L.J. ; Einarsson, G.G....
Journal of Cystic Fibrosis.  21 (2022)  - p. S107 , 2022
Link: https://doi.org/10.1016/..
 
?
8

P115 Comparison of total bacterial and Pseudomonas aerugino..:

Houston, C.J. ; Tunney, M.M. ; Taggart, C.C..
Journal of Cystic Fibrosis.  21 (2022)  - p. S96 , 2022
Link: https://doi.org/10.1016/..
 
?
9

ePS3.05 Induced levofloxacin resistance persists in evolved..:

Sloan, C.M. ; Sherrard, L.J. ; Einarsson, G.G...
Journal of Cystic Fibrosis.  21 (2022)  - p. S50 , 2022
Link: https://doi.org/10.1016/..
 
?
10

P116 Clinical characteristics of frequent and infrequent pu..:

Houston, C.J. ; Taggart, C.C. ; Downey, D.G.
Journal of Cystic Fibrosis.  20 (2021)  - p. S74 , 2021
Link: https://doi.org/10.1016/..
 
?
11

P039 The clinical impact of triple CFTR modulator therapy i..:

Fanthorpe, O. ; Caskey, S. ; Downey, D.G.
Journal of Cystic Fibrosis.  20 (2021)  - p. S50 , 2021
Link: https://doi.org/10.1016/..
 
?
12

P149 Evolution of levofloxacin resistance and phenotypic ch..:

Sloan, C.M. ; Sherrard, L.J. ; Einarsson, G.G...
Journal of Cystic Fibrosis.  20 (2021)  - p. S84-S85 , 2021
Link: https://doi.org/10.1016/..
 
?
13

P149 A review of the clinical trajectory of adults with cys..:

Bradley, C. ; McKeown, C. ; Rutherford, C....
Journal of Cystic Fibrosis.  19 (2020)  - p. S98 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Building global development strategies for cf therapeutics ..:

Mayer-Hamblett, N. ; van Koningsbruggen-Rietschel, S. ; Nichols, D.P....
Journal of Cystic Fibrosis.  19 (2020)  5 - p. 677-687 , 2020
Link: https://doi.org/10.1016/..
 
?
15

WS03.3 A review of ursodeoxycholic acid prescribing in an a..:

Bradley, C. ; Rutherford, C. ; McParland, C....
Journal of Cystic Fibrosis.  19 (2020)  - p. S5 , 2020
Link: https://doi.org/10.1016/..
 
1-15